Natixis Portfolio holdings
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$379M |
| 2 |
NVIDIA
NVDA
|
+$323M |
| 3 |
Amazon
AMZN
|
+$133M |
| 4 |
UnitedHealth
UNH
|
+$97.5M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$86.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$89.2M |
| 2 |
ExxonMobil
XOM
|
+$83.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$83.1M |
| 4 |
CVS Health
CVS
|
+$82.2M |
| 5 |
Eli Lilly
LLY
|
+$66.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.23% |
| 2 | Healthcare | 11.42% |
| 3 | Energy | 7.9% |
| 4 | Consumer Discretionary | 6.67% |
| 5 | Financials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Advance Auto Parts
AAP
$3.37B
| – | – |
-494
| Closed | -$34.7K |
|
952
ABM Industries
ABM
$2.8B
| – | – |
-9,300
| Closed | -$397K |
|
953
Analog Devices
ADI
$181B
| – | – |
-126,921
| Closed | -$24.7M |
|
954
Ameren
AEE
$31.5B
| – | – |
-277
| Closed | -$22.6K |
|
955
Alamos Gold
AGI
$12.4B
| – | – |
-1,131,742
| Closed | -$13.5M |
|
956
Agilon Health
AGL
$1.64B
| – | – |
-9,336
| Closed | -$4.05M |
|
957
Albemarle
ALB
$13.5B
| – | – |
-5,802
| Closed | -$1.29M |
|
958
Allegro MicroSystems
ALGM
$8.58B
| – | – |
-57,800
| Closed | -$2.61M |
|
959
Autoliv
ALV
$8.6B
| – | – |
-7
| Closed | -$595 |
|
960
Ardelyx
ARDX
$1.24B
| – | – |
-600
| Closed | -$2.03K |
|
961
Alexandria Real Estate Equities
ARE
$8.88B
| – | – |
-17,928
| Closed | -$2.03M |
|
962
Alliance Resource Partners
ARLP
$3.18B
| – | – |
-1,269,500
| Closed | -$23.5M |
|
963
Ashland
ASH
$3.04B
| – | – |
-35,400
| Closed | -$3.08M |
|
964
ASML
ASML
$675B
| – | – |
-4,544
| Closed | -$3.29M |
|
965
AngloGold Ashanti
AU
$40.3B
| – | – |
-160
| Closed | -$3.37K |
|
966
Anavex Life Sciences
AVXL
$222M
| – | – |
-8,000
| Closed | -$65K |
|
967
Avery Dennison
AVY
$12.3B
| – | – |
-12,860
| Closed | -$2.21M |
|
968
Acuity Brands
AYI
$9.88B
| – | – |
-16,964
| Closed | -$2.77M |
|
969
AstraZeneca
AZN
$263B
| – | – |
-36,442
| Closed | -$5.22M |
|
970
Banco Bradesco
BBD
$38.1B
| – | – |
-2
| Closed | -$7 |
|
971
Best Buy
BBY
$18B
| – | – |
-1,987
| Closed | -$163K |
|
972
Brunswick
BC
$5.19B
| – | – |
-9,200
| Closed | -$797K |
|
973
Brown-Forman Class B
BF.B
$12B
| – | – |
-24,888
| Closed | -$1.66M |
|
|
974
Brown-Forman Class A
BF.A
$12.3B
| – | – |
-534
| Closed | -$36.3K |
|
975
Brighthouse Financial
BHF
$3.63B
| – | – |
-29,300
| Closed | -$1.39M |
|
Similar funds
Natixis's Q3 2023 Portfolio in Review
As of Q3 2023, Natixis held 1,188 positions worth $13.1B, up 6.1% from $12.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Natixis deployed $1.16B of net new capital in Q3 2023, opening 182 new positions and adding to 340 existing holdings. Its largest new stake was Oneok: 965,015 shares worth $61.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 21% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $89.2M trimmed.
- Natixis's largest Q3 2023 buy was Oneok: 965,015 shares worth $61.2M.
- Natixis added most to Apple in Q3 2023, an estimated $379M increase.
- Natixis's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $89.2M.
- Natixis fully exited Bristol-Myers Squibb in Q3 2023, selling an estimated $83.1M.
- Natixis's ten largest holdings make up 38% of its $13.1B portfolio in Q3 2023.
- Natixis opened 182 new positions and closed 221 in Q3 2023.
- Natixis's portfolio value rose 6.1% quarter-over-quarter to $13.1B.
Based on Natixis's 13F filing for Q3 2023, filed 14 Nov 2023.